QuantPharm LLC, North Potomac, MD, USA.
J Pharmacokinet Pharmacodyn. 2018 Feb;45(1):23-34. doi: 10.1007/s10928-017-9546-9. Epub 2017 Sep 16.
The emerging discipline of mathematical pharmacology occupies the space between advanced pharmacometrics and systems biology. A characteristic feature of the approach is application of advance mathematical methods to study the behavior of biological systems as described by mathematical (most often differential) equations. One of the early application of mathematical pharmacology (that was not called this name at the time) was formulation and investigation of the target-mediated drug disposition (TMDD) model and its approximations. The model was shown to be remarkably successful, not only in describing the observed data for drug-target interactions, but also in advancing the qualitative and quantitative understanding of those interactions and their role in pharmacokinetic and pharmacodynamic properties of biologics. The TMDD model in its original formulation describes the interaction of the drug that has one binding site with the target that also has only one binding site. Following the framework developed earlier for drugs with one-to-one binding, this work aims to describe a rigorous approach for working with similar systems and to apply it to drugs that bind to targets with two binding sites. The quasi-steady-state, quasi-equilibrium, irreversible binding, and Michaelis-Menten approximations of the model are also derived. These equations can be used, in particular, to predict concentrations of the partially bound target (RC). This could be clinically important if RC remains active and has slow internalization rate. In this case, introduction of the drug aimed to suppress target activity may lead to the opposite effect due to RC accumulation.
新兴的数学药理学领域位于高级药物代谢动力学和系统生物学之间。该方法的一个特点是应用先进的数学方法来研究生物系统的行为,这些行为由数学(通常是微分)方程来描述。数学药理学(当时还没有这个名称)的早期应用之一是制定和研究靶介导的药物处置 (TMDD) 模型及其近似模型。该模型不仅在描述药物-靶相互作用的观测数据方面非常成功,而且在推进对这些相互作用的定性和定量理解及其在生物制品的药代动力学和药效动力学特性中的作用方面也非常成功。原始形式的 TMDD 模型描述了具有一个结合位点的药物与靶标(也只有一个结合位点)的相互作用。在为具有一对一结合的药物制定的框架之后,这项工作旨在描述一种用于处理类似系统的严格方法,并将其应用于与具有两个结合位点的靶标结合的药物。还推导出了模型的准稳态、准平衡、不可逆结合和米氏-门捷列夫近似。这些方程特别可用于预测部分结合的靶标 (RC) 的浓度。如果 RC 保持活性且内化速率较慢,这在临床上可能很重要。在这种情况下,由于 RC 积累,引入旨在抑制靶标活性的药物可能会导致相反的效果。